- United States
- /
- Medical Equipment
- /
- NasdaqGM:TCMD
Tactile Systems Technology Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
Tactile Systems Technology (NASDAQ:TCMD) Third Quarter 2022 Results
Key Financial Results- Revenue: US$65.3m (up 24% from 3Q 2021).
- Net loss: US$2.28m (loss narrowed by 32% from 3Q 2021).
- US$0.11 loss per share (improved from US$0.17 loss in 3Q 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Tactile Systems Technology Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 6.3%. Earnings per share (EPS) missed analyst estimates by 29%.
Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are up 16% from a week ago.
Balance Sheet Analysis
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Tactile Systems Technology's balance sheet and an in-depth analysis of the company's financial position.Valuation is complex, but we're here to simplify it.
Discover if Tactile Systems Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGM:TCMD
Tactile Systems Technology
A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
Undervalued with reasonable growth potential.